Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 18Gastrointestinal 11Gynecologic 9Thoracic 5Genitourinary 4Other 3Lymphoid 3Head & Neck 3Dermatologic 3CNS 3Endocrine 2Other hematologic neoplasm 1Classical hematology 1

Conditions

Neuroendocrine Tumors 531Multiple Endocrine Neoplasia Type 1 187Pituitary Neoplasms 186Thyroid Cancer, Papillary 178Pheochromocytoma 152Carcinoma, Neuroendocrine 140Thyroid Neoplasms 130Neoplasms 107Carcinoid Tumor 99Paraganglioma 98Adrenocortical Carcinoma 92Thyroid Carcinoma, Anaplastic 82Pancreatic Neoplasms 69Neoplasm Metastasis 67Insulinoma 61Adrenal Gland Neoplasms 61Gastro-enteropancreatic neuroendocrine tumor 58Carcinoma, Medullary 58Adenocarcinoma, Follicular 58Carcinoma, Non-Small-Cell Lung 57Breast Neoplasms 56Adenoma, Islet Cell 56Lung Neoplasms 50Sarcoma 49Colorectal Neoplasms 49Carcinoma, Renal Cell 49Melanoma 47Small Cell Lung Carcinoma 45Prostatic Neoplasms 44Head and Neck Neoplasms 43

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Behavior × Endocrine × Clear all
NCT03781453 2020-04-08

POWERPLAY Phase 2: Development and Evaluation in Male-dominated Workplaces

University of British Columbia

Phase NA Completed
498 enrolled
Endocrine

Behavior, Health Behavior, Multiple Endocrine Neoplasia Type 1

NCT03548077 2019-10-08

POWERPLAY

University of British Columbia

Phase NA Completed
227 enrolled
Endocrine

Behavior, Neoplasms, Health Behavior, Multiple Endocrine Neoplasia Type 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡